European Innovation Council

Astrape powers the future of datacenters: more bandwidth, less power.

PrecisionLife is a company focused on advancing precision medicine by leveraging its proprietary artificial intelligence platform to enhance the understanding of chronic diseases. It specializes in patient stratification, which allows for the identification of novel subgroups within patient populations, thereby generating insights that inform the discovery of new drug targets and drug repositioning candidates. By utilizing unique and patentable biomarkers, PrecisionLife connects patients with specific disease sub-groups and potential therapies, ultimately aiming to create personalized treatment alternatives. The company’s innovative approach not only drives advancements in biopharmaceuticals but also seeks to improve patient outcomes, enabling individuals to lead longer and healthier lives.

Deeploy is a developer of a machine learning operations platform focused on enhancing the accountability and transparency of AI systems. The platform centralizes explainable AI (XAI) within machine learning operations (MLOps), empowering users to comprehend how models function and to rectify automated decisions when necessary. By organizing deployments, tracking model performance, generating trace logs, and facilitating the creation of custom models and explainers, Deeploy provides data scientists and users with the tools needed to understand the implications and applications of machine learning models. This approach ensures that AI systems are both trustworthy and accountable.

Hideez is a cybersecurity startup that specializes in providing solutions for both physical and logical access. With offices in the USA and Ukraine, the company has developed the Hideez Key, a hybrid device designed for wireless authentication and password management. This innovative solution integrates RFID door credentials and digital signatures, utilizing encrypted Bluetooth, RFID, and NFC technologies. Hideez Key offers a versatile approach to authentication, enabling users to manage and replace credentials remotely. Its proprietary encryption protocols are platform agnostic and are designed to enhance existing solutions in the market. Overall, Hideez aims to simplify identity and access management while ensuring the security of digital assets.

Oryl Photonics develops a laboratory instrument for pharmaceutical and biotech companies that provides simple, reliable, cost-effective and sustainable solubility measurement to accelerate drug development for better and effective medicine.

MediWound Ltd. is a biopharmaceutical company that specializes in the development, manufacturing, and commercialization of innovative therapeutic products aimed at addressing unmet medical needs, particularly in the areas of severe burns and chronic wounds. Founded in 2000 and headquartered in Yavne, Israel, it markets NexoBrid, a biopharmaceutical agent designed for the removal of eschar, or dead tissue, in patients with severe burns. NexoBrid has completed clinical development and is approved for use in Europe. The company is also advancing other products in its pipeline, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic wounds, and MWPC003 for connective tissue disorders. MediWound aims to improve patient outcomes and reduce the complications associated with traditional surgical interventions in wound management.

King's College London (informally King's or KCL) is a public research university located in London, United Kingdom, and a constituent college of the federal University of London. King's is arguably the third-oldest university in England, having been founded by King George IV and the Duke of Wellington in 1829, receiving its royal charter in the same year. St Thomas' Hospital, which is now a teaching hospital of King's College London School of Medicine, has roots dating back to 1173. In 1836, King's became one of the two founding colleges of the University of London. King's is based in the centre of London and organised into nine academic schools, spread across four Thames-side campuses in central London and another in Denmark Hill in south London. It is one of the largest centres for graduate and post-graduate medical teaching and biomedical research in Europe; it is home to six Medical Research Council centres for <a href="https://www.dissertationcorp.co.uk/">dissertation help</a> , the most of any British university, and is a founding member of the King's Health Partners academic health sciences centre. King's has around 25,000 students and 6,113 staff and had a total income of £587 million in 2012/13, of which £164 million was from research grants and contracts. King's is a world-leading university, currently ranked 19th in the world (6th in the UK and 8th in Europe) in the 2013 QS World University Rankings, and 38th in the world (6th in the UK and 9th in Europe) in the 2013 Times Higher Education World University Rankings. There are currently 12 Nobel Prize laureates amongst King's alumni and current and former faculty. King's is a member of the Association of Commonwealth Universities, the European University Association, the Russell Group and Universities UK. It forms part of the 'golden triangle' of British universities.

Bank of Memories helps to organize memories and documents and pass them on to the right people.

ProFuse Technology specializes in advancing cultured meat production by enhancing methods and efficiency. The company has developed innovative technology that significantly reduces production time while improving meat quality and increasing yields. By accelerating muscle fiber growth, ProFuse enables meat producers to enhance their production capacity and lower costs, making cultured meat more accessible and sustainable.

Vitestro is a company focused on enhancing patient care through innovative autonomous blood drawing technology. It develops medical robotic devices tailored for use in hospitals and clinical laboratories. The company’s key product utilizes multi-dimensional ultrasound to detect nerves and arteries, leveraging deep learning to minimize the risk of arterial complications during blood draws. This advanced technology not only aids healthcare professionals in performing procedures with greater precision but also aims to improve overall patient health outcomes by reducing complications associated with traditional blood collection methods.

DRONAMICS is a cargo drone airline that develops drone technology for cargo transportation and logistics operations. The company is building an air cargo ecosystem to cater to the requirements of individuals and industries across the globe. This mobility solution, driven by long-range cargo drones, delivers savings in time, costs, and carbon emissions.

Smart Farm Robotix manufactures agricultural robots that handle the difficulties of manual weeding, herbicide use, and machine weeding.

RespiQ is a healthtech startup that specializes in portable, non-invasive breath analysis technology aimed at the early detection and management of respiratory diseases. By utilizing advanced emission spectroscopy and artificial intelligence, RespiQ's device identifies volatile organic compounds (VOCs) in breath, enabling real-time detection of conditions such as COPD exacerbations. The company's focus on affordability, portability, and user-friendliness seeks to democratize access to advanced diagnostics, ultimately improving patient outcomes and reducing healthcare costs. In addition to respiratory diseases, RespiQ's versatile platform has potential applications for asthma, lung cancer, and infectious diseases. The company also offers an app that provides personalized health insights and dietary guidance, allowing users to monitor their health proactively. RespiQ's combination of technical and healthcare expertise positions it as a leader in breath diagnostics, with a commitment to enhancing overall health and well-being.

NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Acorai is developing a non-invasive heart failure monitoring platform centered on direct intracardiac pressure monitoring (ICPM). The company utilizes a patented combination of sensor technologies and machine learning to provide accurate and cost-efficient heart failure care. This innovative approach allows for non-invasive monitoring of cardiac and pulmonary pressure, which is crucial for improving outcomes in heart failure patients. By analyzing pressure dynamics through acoustic, vibratory, and waveform data, the device enables healthcare professionals to proactively adjust medications, potentially reducing re-hospitalization and mortality rates associated with heart failure. Clinically validated and designated as an FDA Breakthrough Device, Acorai's product is expected to enter the market in 2025.

RAIKU is a cleantech startup that produces 100% natural packaging material that has also great looks and shock absorption - most importantly, it gives 15-20 times more volume to its raw material making it one of the most resource efficient material uses in the world with high margins. Both the production is and products are clean making no harm to nature. RAIKU has raised over 1.2mln€ in the pre-seed stage, built a team of over 10 people, its own IP and clients are already using its packaging material. This material will up-end the 1 trillion € packaging sector.

VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.

PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

Pulse is a platform for furthering our understanding of bioprinting and its applications in space exploration and medicine.

Elgan Pharma is a biotechnology company specializing in neonatology, dedicated to addressing medical challenges and developmental issues faced by premature infants. The company is focused on developing innovative therapies utilizing nanotechnology to prevent visual impairment, a common and multifactorial problem in preterm babies. By targeting the specific needs of this vulnerable population, Elgan Pharma aims to enhance visual outcomes and reduce the risk of significant disabilities, ultimately supporting healthcare professionals in their efforts to improve the quality of life for these infants.

Cellbox Solutions is a young technology company that focuses on innovative logistic solutions for the global BioMed industry.

Woodio is a design-oriented company that specializes in innovative material technology for bathroom applications. The firm has developed a fully waterproof wood composite made from real wood chips, allowing for a range of design options while prioritizing sustainability. This technology offers customers fully recyclable biomaterials, enabling them to enhance and redesign their bathrooms with eco-friendly solutions. Woodio's focus on combining aesthetics with functionality positions it as a unique player in the market for bathroom design materials.

Escala Medical is focused on developing a minimally invasive medical device aimed at treating pelvic organ prolapse (POP) in women. The company's innovative system offers a nonsurgical, incision-free, and mesh-free repair option that addresses the vaginal apex by connecting it to the sacrospinous ligament. This approach is designed to be safe, quick, and to preserve organ functionality while minimizing patient discomfort. The procedure can be performed in outpatient and office-based settings, providing a much-needed alternative for women suffering from POP.

Cupffee specializes in the production of edible and biodegradable coffee cups and stirrers, offering a sustainable alternative to traditional disposable cups. Their manufacturing process is environmentally friendly, generating no industrial waste and only producing clean steam along with the pleasant aroma of freshly baked cookies. Additionally, any leftover materials from the cup production are repurposed as ingredients for other edible products, further enhancing their commitment to sustainability. Unlike conventional disposable cups, Cupffee's products decompose within days, allowing consumers to dispose of them in an environmentally responsible manner.

The Intelligence Behind Global Circularity VCG.AI transforms industrial by-products and waste into valuable resources. AI-powered development of circular economy business models with the latest technology, material, market, and regulatory insights. Their proprietary AI solution, the Value Chain Generator®, helps companies, cities, and regions accelerate the transition to a circular economy, through Valorisation of By-products and Waste, Circular Product Development, Regional Circular Opportunities Assessment. When organisations want to better valorise by-products and waste, develop or source circular materials, or enhance circularity in their value chains, VCG.AI analyses thousands of data points to deliver the optimal solution tailored to their specific needs and locations. What once took months or years can now be achieved in just weeks—without the need to hire additional technology or bioeconomy experts. VCG.AI’s ever-expanding system includes: - 650+ validated circular solutions - 150+ different proven valorisation technologies - 3.5 M companies - 4M tons of project-ready organic residuals across Europe VCG.AI is on a mission to accelerate the transition to a circular economy by unlocking circular opportunities for businesses worldwide. Learn more about them at www.vcg.ai.

3DSecret is developing cutting-edge technologies to uncover the stochastic patterns behind metastasis in order to predict the course of cancer.

Norbite is a biotech research firm that transforms plastic waste into sustainable goods using an insect-based biorefinery.

Agurotech develops soil sensing technology. They offer products that include robust and highly reliable sensing technology, tailored irrigation recommendations, and continuous improvement of the irrigation process.

Inobiostar focuses on research and experimental development services.

Naco Technologies Ltd specializes in the development, manufacturing, and supply of advanced nano coating technologies to a global clientele. Founded in 2009 and based in Riga, Latvia, the company offers a variety of high-performance coatings, including oil-enhanced, wear-protective, thermal barrier, and liquid-repellent solutions tailored for industries such as tooling, automotive, aerospace, and micro-chip production. In recent years, Naco has focused on supporting the hydrogen sector by building a manufacturing facility that provides ready-to-use coated parts for hydrogen production systems. By developing multilayer and multicomponent coatings specifically for green hydrogen applications like electrolyzers and fuel cells, Naco aims to enhance the reliability of these systems while minimizing the need for costly and scarce materials. In 2015, Naco was acquired by the Schaeffler Group, a Germany-based company.

Nemysis Limited is a specialty pharmaceutical company founded in 2005 and based in Dublin, Ireland. The company focuses on addressing unmet needs in nutritional disorders and deficiencies through a unique staged approach to product development. Nemysis manufactures a range of food supplements, medical matrix products, and prescription items, targeting the same medical conditions across different market segments. Notable products include a novel gastric and trypsin-resistant formulation designed for oral enzymatic therapy in patients with celiac disease, as well as an iron supplement that acts as a medical device to neutralize gluten, aimed at alleviating symptoms for individuals with celiac disease and non-celiac gluten sensitivity. This strategy allows Nemysis to cater to patients with iron deficiency or anemia while minimizing gastrointestinal side effects associated with traditional iron supplementation.

Smart Immune is a clinical-stage biotechnology company focused on developing innovative hematopoietic stem cell-based therapies aimed at improving the prognosis and quality of life for patients with serious diseases. The company's primary program utilizes T cell progenitors, known as ProTcells, which are designed to facilitate a rapid and safe immune recovery following transplantation. This therapy seeks to provide a polyclonal immune response, enhancing the body's ability to combat cancers and infections. Additionally, Smart Immune plans to complement its core offerings with advancements in targeted conditioning, gene therapy, and genome editing, thereby creating next-generation treatments for a range of inherited blood disorders and hematological malignancies.

Samplix is a biotechnology company based in Herlev, Denmark, focused on single-molecule sample preparation for DNA and RNA. It has developed the Xdrop™ technology, which utilizes a unique “water-oil-water” droplet system to create millions of reaction chambers for handling individual DNA molecules. This innovative approach allows for targeted enrichment of large DNA fragments and enables researchers to sequence specific genetic regions effectively. Samplix's technology addresses the limitations of existing multi-molecule preparation methods, providing enhanced precision and sensitivity while simplifying the sample preparation process. Its solutions empower scientists to make informed research decisions, particularly in applications related to virus integration and CRISPR editing.

Miwa is a retail solution provider focused on minimizing single-use packaging through a circular economy strategy. The company offers a system that includes reusable containers designed to reduce waste and promote sustainability. These sealable and reusable containers work alongside electronic dispensers located in retail environments, facilitating the bulk distribution of both food and non-food products. By enabling producers and retailers to store and dispense items in a hygienic manner, Miwa aims to create a more efficient and environmentally friendly approach to retail.

GrayMatters Health delivers beyond the pill digital therapeutics for mental disorders through volitional regulation of brain processes.

Qurv develops wide-spectrum image sensor technologies and integrated solutions to enable next-gen computer vision applications, addressing the expanding needs of an autonomous and intelligent new world. Qurv's technology leverages current CMOS scalable manufacturing and advanced materials to unlock new levels of performance, reliability and function in XR devices, service robots and automotive. Qurv's breakthrough technology platform stemmed from more than eight years of applied research, and the company was established in 2020.

IDloop specializes in biometric technology, focusing on contactless fingerprint sensor solutions tailored for both business and government markets. The company’s innovative technology captures secure three-dimensional images of multiple fingers, which significantly reduces false acceptance rates and enhances overall security. By leveraging advanced 3D imaging, artificial intelligence, and embedded technology, IDloop aims to provide efficient and reliable biometric identification, addressing the growing demand for secure access solutions in various sectors.

Valo Therapeutics is an immunotherapy company based in Oxford, United Kingdom, with an additional office in Helsinki, Finland. Founded in 2016, the company focuses on developing antigen-coated oncolytic viruses as therapeutic vaccines for cancer treatment. Its primary platform, PeptiCRAd, is an engineered human oncolytic adenovirus designed to stimulate a systemic anti-tumor T cell response. This innovative approach enables the conversion of oncolytic adenoviruses into targeted, tissue-specific cancer vaccines without the need for multiple genetically modified viruses. Additionally, Valo Therapeutics is working on other strategies, such as PeptiENV, to enhance therapeutic responses to enveloped oncolytic viruses across various cancer types. By utilizing tumor-specific peptides, the company aims to elicit a robust adaptive immune response, potentially providing lasting immunity against multiple cancers and improving patient outcomes.

TILT Biotherapeutics Ltd is a preclinical stage biotechnology company based in Helsinki, Finland, specializing in the development of genetically modified oncolytic viruses aimed at enhancing cancer treatments. The company's patented technology focuses on using these viruses to improve tumor T-cell therapies, including tumor-infiltrating lymphocyte (TIL) and chimeric antigen receptor (CAR-T) therapies, as well as checkpoint inhibitors. TILT Biotherapeutics is recognized as a leader in the global market for integrating oncolytic viruses with cancer immunotherapy. Their product pipeline includes TILT-123, TILT-234, and TILT-321, which are designed to modify the tumor microenvironment and counteract its suppression of immune responses. The innovative approach has the potential to replicate the successes seen in CAR-T therapy for solid tumors, similar to those achieved in hematological cancers.

We make waste management simpler by providing data in an accessible, clear and efficient way to environmental professionals. NANDO, is a cutting-edge artificial intelligence, that delivers actionable insights for measuring, analyzing, and optimizing waste management. This empowers companies and communities to minimize their waste impact, safeguarding the planet for future generations.

Sostre Cvic is a non-profit organization that promotes an alternative model of housing access under the scheme.

Efficient Energy Technology makes renewable energy simple, safe, and dependable for everyone. Efficient Energy Technology develops a small power plant consisting of photovoltaic and storage for complete self-installation.

Kvantify, founded in 2022 and headquartered in Copenhagen, Denmark, specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. The company's platform focuses on enhancing drug discovery processes by employing proprietary physics-based methods to improve the quality of compounds tested in laboratories. By providing advanced computational drug technology, Kvantify enables life sciences companies to accelerate small molecule research and obtain actionable results that significantly impact their operations.

Iris.ai offers an AI-powered science assistant designed to enhance the efficiency of research and development departments by facilitating the navigation of scientific literature. Its primary product, RSpace, features advanced search capabilities, smart filters, reading list analysis, auto-generated summaries, and automated data extraction, enabling users to systematically organize information. By leveraging natural language processing algorithms, Iris.ai addresses the challenges of factuality tracking in AI, providing tools that enhance the accuracy and reliability of scientific research. This platform is aimed at both corporate R&D teams and academic researchers, allowing them to uncover new scientific insights that go beyond traditional human capabilities.

iLoF, or Intelligent Lab on Fiber, is a developer of a digital health platform that utilizes advanced photonics and artificial intelligence to enhance personalized drug discovery and development. The company has created a patented system that identifies and captures unique features of gold-standard biomarkers, compiling this information into a cloud-based library. By leveraging this extensive database, iLoF aims to facilitate collaboration among physicists, biologists, and data scientists, ultimately improving the efficiency and patient-centricity of clinical trials. This innovative approach not only reduces the costs associated with drug development but also aims to provide patients with tailored, life-saving treatments.

Energy Dome is an Italian company based in Lonate Pozzolo that specializes in long-duration electricity storage using liquid carbon dioxide. The company has developed a low-cost and efficient technology that employs a closed-loop thermodynamic process to store energy, making renewable power more dispatchable. By focusing on energy storage solutions, Energy Dome aims to facilitate the transition to renewable energy and contribute to the decarbonization of the energy industry. Its innovative approach seeks to address climate change challenges by significantly reducing greenhouse gas emissions, thereby promoting a more sustainable future.

FreezeM is focused on advancing preservation technologies that enhance the use of insects as a sustainable protein source for the animal feed industry. The company is developing innovative methods for large-scale freezing of insects, which will facilitate the creation of global stocks of frozen insect neonates and eggs. This approach aims to address critical challenges related to the availability, cost, and regulatory hurdles associated with utilizing insects in animal feed. By ensuring a stable and year-round production of these beneficial insects, FreezeM seeks to make a significant impact on the animal feed market, while also contributing to biological pest control and species preservation.

Releaf Paper is a producer of sustainable paper products that utilizes fallen leaves as a raw material, aiming to reduce the environmental impact associated with traditional paper production. By sourcing leaves from city parks and other urban areas, Releaf Paper offers an innovative alternative to wood-based paper. Their technology not only addresses sustainability concerns but also minimizes water and energy consumption in the manufacturing process. This approach enables paper manufacturers to adopt more environmentally friendly practices while contributing to a circular economy.

Dxcover is a clinical-stage liquid biopsy company based in Glasgow, founded in 2016 by David S Palmer, Holly Butler, and Matthew Baker. The firm focuses on developing innovative diagnostics for the early detection of various cancers, which is crucial for improving treatment outcomes. Dxcover has pioneered the use of infrared spectroscopy combined with artificial intelligence to analyze circulating pan-omic indicators, allowing for the identification of cancer from a simple blood sample. This approach enables same-day diagnosis and patient stratification, facilitating timely interventions. The company has demonstrated strong clinical data supporting the accurate diagnosis of Stage I and Stage II cancers, underscoring its commitment to enhancing survival rates and quality of life for patients.

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Kern Tec specializes in upcycling fruit kernels from stone fruits, specifically cherries, apricots, and plums, to create innovative food products. The company refines these kernels into high-quality raw materials suitable for various applications, including baking ingredients, sustainable cosmetic oils, fertilizers, and biomass. By focusing on environmentally friendly processes, Kern Tec provides clients in the baking, food supplement, dairy alternatives, and confectionery industries with naturally sourced materials, promoting sustainability while meeting industry demands.

Blue Planet Ecosystems Incorporated, founded in 2018 and based in San Francisco, California, specializes in the development and operation of modular closed-loop photoprotein reactors that facilitate sustainable food production, particularly seafood, in extreme environments. The company's innovative technology mimics natural aquatic ecosystems, allowing for the conversion of sunlight and carbon dioxide into essential nutrients such as sugars, amino acids, and fatty acids. This process supports the production of organic seafood close to consumers, promoting a more efficient and environmentally friendly approach to aquaculture. By enabling farmers and agricultural businesses to diversify their methods, Blue Planet Ecosystems aims to address the challenges posed by climate change and enhance food security.

iOnctura is a biopharmaceutical company that develops novel therapeutics aimed at addressing immunosuppression within the tumor microenvironment, which can hinder effective cancer treatment. The company focuses on creating next-generation biomolecules to enhance existing immune checkpoint therapies, ultimately aiming to improve patient outcomes in cancer treatment. Through collaborations with Merck and Cancer Research Technology, iOnctura is advancing a pipeline of preclinical molecules designed to be used in combination with immuno-oncology therapies. With access to state-of-the-art drug discovery laboratories and a network of academic partners, iOnctura is strategically positioned to develop innovative combination therapies in cancer immunology, ensuring a focused approach to tackling the complexities of cancer and fibrosis.

Herantis Pharma is a biotechnology company focused on addressing unmet clinical needs through the development of disease-modifying therapies for Parkinson's disease. The company's primary development program centers on HER-096, a peptidomimetic molecule engineered to preserve the biological activity of the neuroprotective CDNF protein. By targeting the underlying mechanisms of the disease, Herantis Pharma aims to provide innovative treatment options for patients suffering from Parkinson's disease.

FOx Biosystems is a biotechnology company improving biomolecular interaction analysis in life science research and industry. The company offers services in the development of custom applications e.g. custom probes, evaluation support, development of custom devices, and system support. It also enables the users to generate high-quality biomolecular data such as concentration measurements., affinity data, and kinetic data. FOx Biosystems aims to revolutionize the life sciences industry and research market using its real-time, label-free analysis technology. It was founded in 2017 by Filip Delport and Jeroen Lammertyn and is headquartered in Temse, Oost-Vlaanderen, Belgium.

Vésale Pharma work with internationally renowned research organizations.They offer innovative healthcare solutions adapted to everyone.

NC Biomatrix is focused on developing medical therapies aimed at restoring the natural biomechanics of the spine to address low back pain. The company offers a non-invasive treatment option that involves an injectable viscous gel designed to alleviate the underlying causes of lower back pain. By targeting the biomechanics of the spine, NC Biomatrix provides a novel solution for patients suffering from osteoarthritis and related conditions, improving their quality of life through effective pain management.

DeepOpinion is a cognitive automation platform designed for businesses to streamline operations and enhance productivity by automating repetitive processes involving unstructured data. The platform features a no-code interface that allows users to quickly create automation workflows, supporting various industries in their efforts to improve efficiency. Utilizing a proprietary auto-machine learning engine, DeepOpinion enables developers and data scientists to employ advanced deep learning technology for natural language processing (NLP) models. Its intelligent process capabilities facilitate the decoding of human opinions into actionable insights, making it easier for clients to automate text-based tasks through a user-friendly drag-and-drop workflow builder.

Gold Standard Phantoms specializes in the development, marketing, and sale of calibration services and devices for quantitative medical imaging, particularly focusing on MRI scanners. The company provides a cloud-based data analysis platform that ensures the calibration of images is traceable to standardized values. Its innovative cylindrical phantom design addresses the need for multiple sample vials during phantom preparation, allowing clinicians, medical physicists, and radiographers to obtain reproducible quantitative measurements of diseases across different patients, scanners, and clinics. This approach not only enhances the accuracy of MRI imaging but also holds the potential to reduce medical costs over time.

Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results are state-of-the-art, providing at least a 50% efficiency gain over the previous standards

inPhocal is a company that specializes in advanced laser processing technology, utilizing a unique laser beam system originally developed from CERN research. The firm focuses on specialized printing solutions, offering undeletable prints for critical applications such as expiration dates and batch codes. Their innovative marking printer operates without ink, providing a faster alternative to traditional marking machines while maintaining high-quality prints on uneven surfaces. This technology aims to enhance current optical printing methods, positioning inPhocal as a leader in the field of laser processing.

EmbeDL specializes in developing optimization software aimed at enhancing artificial intelligence and deep learning models. The company offers a state-of-the-art Deep Learning Model Optimization SDK, which significantly reduces energy consumption by up to 94%, increases execution speed by 16 times, and compresses memory models by a factor of eight. This SDK allows users to create energy-efficient deep learning models that can perform in real-time on cost-effective hardware. By combining proprietary algorithms with cutting-edge research innovations, EmbeDL ensures that model accuracy and precision are maintained throughout the optimization process. The company actively collaborates with leading industry players and academic institutions, fostering a culture of innovation that continually advances the field of embedded intelligence. Through these efforts, EmbeDL aims to streamline and automate the generation of superior deep learning models, making it easier for AI teams to develop competitive solutions in the market.

Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

Afon Technology provides non-invasive blood glucose monitoring devices. Their services are non-invasive, pain-free, blood glucose tracking in real-time, continuous detection, potential pre-diabetic identification, alarm alerts, trend profiles, and time-in-range profiles, bluetooth connectivity to smart devices, ios, and android compatible stand-alone sensors, and user interface via app on smart device services.

Water Challenge is a company that provides a disruptive solution based on an economically sustainable technology that allows the treatment of any type of contaminated fluid, extracting all the solids contained, crystallizing, and purifying water suitable for human consumption, irrigation, and other uses.

Newronika is a company focused on restoring brain and body functions through innovative neuro-modulation technologies. It develops therapeutic devices that utilize a retro-activity system to record brain activity and modulate neuro-stimulation. By collecting, analyzing, and interpreting bio-signals, Newronika enables patients to receive timely stimulation, allowing them to engage in normal daily activities and enhance their quality of life. As a spin-off from prominent Italian research institutions, including the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika benefits from a multidisciplinary team of experts in various fields such as neuroscience, neurophysiology, biomedical engineering, and neuropsychology.

Vigor Medical Technologies Ltd. focuses on developing and commercializing innovative devices aimed at treating chest trauma and facilitating thoracic and abdominal drainage. With over four million cases of chest trauma reported annually, which is a leading cause of accidental death, Vigor's products address a critical healthcare need. The company offers self-fixation sealing devices that prevent lung and heart collapse, essential for immediate and effective medical management. Additionally, Vigor has developed a hermetic seal and open drainage shaft that effectively seals wounds against contamination from dirt, blood, cloth, or hair, while also preventing both internal and external bleeding. These features make Vigor's devices valuable for military and civilian first aid organizations, as well as hospitals, enhancing the efficacy of emergency care in critical situations.

Precisis is a medical technology company based in Heidelberg, Germany, founded in 2004. The company focuses on developing innovative medical devices aimed at treating epilepsy and enhancing patients' quality of life. Their flagship product involves a device that delivers individualized brain stimulation through a surgical procedure. This device is precisely positioned beneath the scalp over the epileptic origin in the brain, allowing for targeted therapeutic currents to be directed at specific areas without direct contact with the brain. This approach aims to provide deep and focused stimulation to effectively manage epilepsy.

ValueBioTech Srl is a medical device company helping surgeons with robotic tools that can be integrated into the operating room and with their daily task. Designed by practicing surgeons, the company is engineering robotic tools that facilitate, enhance and perfect laparoscopic technique to deliver better clinical outcomes to millions of patients each year in a safer and more cost effective manner.

Enduro Genetics is a genetic technology provider committed to enabling biomanufacturing and the company work with clients to improve existing or new cell lines and production strains. Through its Enduro Sense technology platform it develops genetic plug-ins, which 'addicts' cell lines and production strains to high and stable production. The technology offers drastic improvements to both well established and new bioprocesses.

Reverion specializes in developing reversible, carbon-negative power plants that leverage patented technology to maximize the potential of biogas. The company's containerized units, designed for mass production, achieve remarkable electrical efficiencies of 80% for both power generation and energy storage. This innovative approach not only doubles the electricity output of traditional gas engines but also significantly reduces greenhouse gas emissions, resulting in a negative CO2 balance. Additionally, Reverion's technology is capable of utilizing excess solar and wind power, enhancing electricity production in existing biogas plants and stabilizing the power grid during electrolysis. Through these advancements, Reverion aims to promote a renewable and decarbonized energy future.

Reblade is a climate-focused deep tech startup that specializes in drone-based and AI-assisted repair technologies for wind turbine blades. The company offers innovative robotic solutions aimed at helping wind farm owners and service providers reduce costs, risks, and service time associated with blade erosion repairs. By utilizing patented technology, Reblade enables its clients to enhance their operational efficiency and achieve significant reductions in carbon emissions. As a recipient of various innovation awards, including Eurostars, Eureka, and the EIC, Reblade presents a compelling business case for the wind energy sector. The company is currently seeking impact investors and strategic partners in Europe, India, and the United States to support its mission and expand its reach in the market for advanced erosion repair solutions.

ALA Diagnostics specializes in the development and marketing of in vitro diagnostic kits aimed at addressing high-prevalence pathologies and unmet medical needs. The company focuses particularly on multiple sclerosis, offering diagnostic kits that facilitate early diagnosis of the condition. These kits are designed for seamless integration into the clinical routines of hospitals and medical centers, enabling healthcare professionals to deliver accurate results. By improving diagnostic capabilities, ALA Diagnostics aims to enhance the quality of life for individuals affected by multiple sclerosis. The company leverages collaborations with public organizations to foster innovative projects and enhance its product offerings.